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ARTICULAR LEVELS OF ADIPONECTIN ARE NOT
CHONDROPROTECTIVE IN 3D CULTURES OF HUMAN
CHONDROCYTES
A. Abot, V. Olive, A. Bianchi, S. Sebillaud, P. Netter, D. Moulin,
J-Y. Jouzeau
Laboratoire de Physiopathologie et Pharmacologie Articulaires,
Vandoeuvre les Nancy, France
Purpose: Adipokines are found in synovial ﬂuid of OA patients
and circulating levels of adiponectin (Apn) are reduced in obe-
sity. As obese patients are at increasing risk of developing os-
teoarthritis (OA), even in non-weight bearing joints, we tested the
hypothesis that low (physiological) concentrations of Apn could
impair chondrocytes functions towards an “OA-like” phenotype.
Methods: Firstly, the expression of Apn and Apn receptors (Adi-
poR) was characterized by quantitative RT-PCR and western
blotting. Secondly, a dose-ranging comparative study of physio-
logical concentrations (0.2, 1 or 5µg/ml) of globular (gApn) and
full length (ﬂApn) forms of adiponectin was performed on chon-
drocytes cultured in alginate beads. The parameters measured
were: proteoglycans (PGs) synthesis (by radiolabelled sulfate in-
corporation), pro-inﬂammatory mediators release (NOx by Griess
method, PGE2 and TNFα by ELISA) and MMP-13 activity (by
ﬂuorimetric assay). Thirdly, in co-stimulation experiments, the
ability of gApn or ﬂApn to modify chondrocytes responses to the
pro-catabolic factor, IL-1beta (10ng/ml) or the pro-anabolic factor,
IGF-1 (50ng/ml) was studied.
Results: We demonstrated that chondrocytes expressed Apn
(mRNA & protein) in monolayers or alginate beads as well as
AdipoR1 (mRNA & Protein) and AdipoR2 (mRNA). We found
that, in the concentration range tested, gApn was inactive on
all parameters except a weak inhibitory effect on MMP-13 at
5µg/mL. In contrast, the highest concentration (5µg/ml) of ﬂApn
was able to decrease PGs synthesis by 27%, to induce NO and
PGE2 release, and to increase MMP-13 activity. A weak effect
was seen for lower concentrations of ﬂApn on PGs synthesis and
MMP-13 activity. Neither gApn nor ﬂApn reduced the stimulating
effect of IGF-1 on PGs synthesis, but ﬂApn weakly potentiated the
inducing effect of IL-1beta on PGE2 release and MMP-13 activity.
Conclusions: This preliminary study shows that, in human chon-
drocytes: i) gApn was less active than ﬂApn; ii) ﬂApn was active
in the upper range of Apn joint levels found in OA patients; iii)
ﬂApn failed to protect from the deleterious effect of IL-1. Our
data do neither support the meaning that Apn could be chon-
droprotective in OA nor that a reduced articular level could be
deleterious for cartilage.
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CHONDROCYTE APOPTOSIS IN ARTICULAR
CARTILAGE: HOW LONG DOES IT TAKE?
A. Tyler, K. Nowlan, C. Thomas, C. Whittles, M. Sharif
University of Bristol, Bristol, United Kingdom
Purpose: Osteoarthritis (OA) is a prevalent degenerative disor-
der, especially in ageing individuals. Loss of articular cartilage
(AC) is a key feature of the disease and recent studies suggest
that a reduction in cell viability may be a trigger for both initiation
and progression of AC damage in OA. Our previous studies have
shown that hypocellularity in OA cartilage can be explained by
apoptosis which is on average 3 times higher in OA cartilage
compared to normal (Sharif et al 2004). The aim of this study
was to determine the time course for chondrocyte apoptosis in
equine AC.
Methods: Equine AC obtained from the metatarsophalangeal
(MTP) joint of 9 horses were incubated with tumour necrosis
factor-alpha (TNF-α) and Actinomycin-D (ActD) for 0, 6, 12, 18,
24 and 48 hours. At each time point cartilage was assessed for
cell viability using ﬂuorescein diacetate (stains live cells green)
and propidium iodide (stains dead cells red) and apoptosis using
indirect immunohistochemistry for active caspase-3 expression.
Results: Cell viability was 89.9 ± 1.3% (Mean ± SEM) at
baseline and decreased linearly to 69.9 ± 5.9% after 24 hours.
Overall levels of cell death after 18 (P<0.05), 24 and 48 hours
(P<0.01) were found to be statistically signiﬁcant. Cell death
by apoptosis (expression of caspase-3) also reached levels of
signiﬁcance after these time points. Apoptosis increased linearly
from 27.1 ± 1.3% at baseline to 58.8 ± 5.1% after 24 hours.
In addition, a signiﬁcant positive correlation (r = 0.53, p<0.001)
was found between the percentages of dead cells and apoptotic
cells.
Conclusions: Our data demonstrated that TNF-α plus ActD
treatment of equine AC over 48 hours results in peak apoptosis
at 24 hours, and that apoptosis contributes signiﬁcantly to the
overall increase in cell death over the 48 hours. These ﬁndings
support the role of chondrocyte apoptosis in the initiation of AC
damage in OA.
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INVESTIGATING SUPEROXIDE DISMUTASE
EXPRESSION IN CARTILAGE AND A POTENTIAL ROLE
IN OSTEOARTHRITIS
J.L. Lindop1, R.K. Davidson2, I.M. Clark2, T.B. Kirkwood1,
D.A. Young1
1Newcastle University, Newcastle Upon Tyne, United Kingdom;
2University of East Anglia, Norwich, United Kingdom
Purpose: To characterise the expression of the superoxide dis-
mutase (SOD) family of antioxidant enzymes in normal and
osteoarthritic cartilage and investigate their potential role in the
development of osteoarthritis (OA).
Methods: SOD gene expression was determined in RNA sam-
ples extracted from the cartilage of 12 normal fracture (NOF)
and 12 OA hips using real time PCR. Immunohistochemistry was
then used to assess the levels of SOD2 protein expression in
NOF and OA hip cartilage sections. Histochemical stains for the
electron transport chain proteins cytochrome c oxidase (COX)
and succinate dehydrogenase (SDH), which are mitochondrially
and nuclear encoded respectively, were used to identify any OA
chondrocytes exhibiting mitochondrial dysfunction as a potential
consequence of damage by reactive oxygen species (ROS). The
mitochondrial genome of individual COX deﬁcient cells was am-
pliﬁed by PCR and the mutational status determined by DNA
sequencing.
Results: The expression of all SOD genes was signiﬁcantly
downregulated at the mRNA level. The downregulation of SOD2
appeared to be the most dramatic and this has been conﬁrmed
at the protein level. COX-SDH histochemistry identiﬁed a pro-
portion of OA chondrocytes having deﬁcient expression of the
mitochondrially encoded COX enzyme.
Conclusions:SOD2 expression has been shown to be downreg-
ulated in OA cartilage compared to NOF cartilage. Subsequently,
OA chondrocytes which contain potentially dysfunctional mito-
chondria have been identiﬁed histochemically and further work
is being carried out to identify whether this is a consequence of
increased levels of mitochondrial DNA (mtDNA) mutation. Mito-
chondrial dysfunction and mtDNA mutation may arise as a result
of the downregulation of SOD2 expression and consequent in-
creased levels of ROS. Future work will examine mtDNA mutation
rates between age-matched OA and normal chondrocytes. We
propose that re-instigation of normal levels of SOD2 expression,
or antioxidant therapy, will reduce oxidative stress and damage
seen in OA and may represent a potential therapy. In certain
